Concepedia

Gerrit Weimann

GW

Statistics

Publications

18

Citations

2.6K

H-Index

14

Active since

2001

Affiliations

Bayer (Germany)(Current)

Medizinische Hochschule Hannover

Imperial College London

Bayer (United States)

Universitätsklinikum Gießen und Marburg

Gerrit Weimann is an author at Bayer (Germany) specializing in medicine, pharmacology, and clinical pharmacology.

ORCID

Publications per year

2001–2025

18

Publications

18

Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

Andrea Maria D’Armini, Friedrich Grimminger, Marius M. Hoeper et al. · New England Journal of Medicine · 2013 · 1.4K citations · Full text

, , +13

First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension

Friedrich Grimminger, Gerrit Weimann, R Frey et al. · European Respiratory Journal · 2009 · 249 citations · Full text

, , +17

Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study

Hossein Ardeschir Ghofrani, Marius M. Hoeper, Michael Halank et al. · European Respiratory Journal · 2010 · 239 citations · Full text

, , +16

Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial

Marius M. Hoeper, Michael Halank, Heinrike Wilkens et al. · European Respiratory Journal · 2012 · 148 citations · Full text

, , +14

Nerandomilast in Patients with Progressive Pulmonary Fibrosis

Toby M. Maher, Shervin Assassi, Arata Azuma et al. · New England Journal of Medicine · 2025 · 139 citations · Full text

, , +13

1–5 of 18